The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy
Dephosphorylation
Sting
DOI:
10.1016/j.celrep.2025.115605
Publication Date:
2025-04-17T18:35:39Z
AUTHORS (19)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....